Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02656485 · ClinicalTrials.gov registry record · Phase 1
A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris
A Phase 1 study, sponsored by AOBiome.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT02656485 is a Phase 1 study that has completed, run by AOBiome. The registered enrollment target is 36 participants.
The verdict
NCT02656485, a Phase 1 study, has completed, sponsored by AOBiome.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a single center, randomized, double-blind, placebo-controlled study in subjects with acne vulgaris.
Interventions
- DRUG Placebo
- DRUG B244
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2015-08-05 |
| Est. Completion | 2016-07-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02656485
The ClinicalTrials.gov registry entry for NCT02656485 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AOBiome, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02656485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02656485 about?
NCT02656485 is a clinical study titled "A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris". This is a single center, randomized, double-blind, placebo-controlled study in subjects with acne vulgaris.
What is the current status of trial NCT02656485?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2015-08-05. Estimated completion is 2016-07-15.
What interventions are being tested in trial NCT02656485?
The interventions under investigation include: Placebo (DRUG), B244 (DRUG).
Who is sponsoring clinical trial NCT02656485?
This trial is sponsored by AOBiome, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.